EIF4A1
Eukaryotic initiation factor 4A-I
Also known as: DDX2A, EIF-4A, EIF4A, IF4A1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P60842
- Gene
- EIF4A1
- Ensembl
- ENSG00000161960
- Chromosome
- 17
- Canonical length
- 406 aa
- Protein class
- Enzymes, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Cytosol
OverviewNCBI Gene
Enables double-stranded RNA binding activity and translation initiation factor activity. Involved in cytoplasmic translational initiation and positive regulation of transcription by RNA polymerase II. Located in nuclear stress granule; perinuclear region of cytoplasm; and plasma membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
406 residues, UniProt reviewed canonical sequence.
>P60842|EIF4A1
1 MSASQDSRSR DNGPDGMEPE GVIESNWNEI VDSFDDMNLS ESLLRGIYAY GFEKPSAIQQ
61 RAILPCIKGY DVIAQAQSGT GKTATFAISI LQQIELDLKA TQALVLAPTR ELAQQIQKVV
121 MALGDYMGAS CHACIGGTNV RAEVQKLQME APHIIVGTPG RVFDMLNRRY LSPKYIKMFV
181 LDEADEMLSR GFKDQIYDIF QKLNSNTQVV LLSATMPSDV LEVTKKFMRD PIRILVKKEE
241 LTLEGIRQFY INVEREEWKL DTLCDLYETL TITQAVIFIN TRRKVDWLTE KMHARDFTVS
301 AMHGDMDQKE RDVIMREFRS GSSRVLITTD LLARGIDVQQ VSLVINYDLP TNRENYIHRI
361 GRGGRFGRKG VAINMVTEED KRTLRDIETF YNTSIEEMPL NVADLILocalizationUniProt · AlphaFold · HPA
Whether an antibody against EIF4A1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.25
- Highest tissue expression
- 532 nTPM
Expression across tissuesHPA
Tissue
- esophagus: 532 nTPM
- urinary bladder: 472 nTPM
- adipose tissue: 466 nTPM
- bone marrow: 379 nTPM
- tonsil: 360 nTPM
- skin: 353 nTPM
Single-cell type
- microglia: 82 nCPM
- oligodendrocytes: 54 nCPM
- other brain neurons: 54 nCPM
- astrocytes: 52 nCPM
- bergmann glia: 50 nCPM
- oligodendrocyte progenitor cells: 48 nCPM
Immune cell
- total PBMC: 2,954 nTPM
- myeloid DC: 1,910 nTPM
- classical monocyte: 1,645 nTPM
- intermediate monocyte: 1,382 nTPM
- non-classical monocyte: 1,083 nTPM
- MAIT T-cell: 756 nTPM
Brain region
- thalamus: 129 nTPM
- white matter: 126 nTPM
- medulla oblongata: 122 nTPM
- hypothalamus: 110 nTPM
- spinal cord: 109 nTPM
- pons: 108 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.12
- gnomAD pLI
- 1
- gnomAD missense Z
- 3.93
- DepMap mean gene effect
- -1.25
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cytoplasmic translational initiation
- positive regulation of transcription by RNA polymerase II
- translational initiation
Molecular functions
- ATP binding
- ATP hydrolysis activity
- double-stranded RNA binding
- helicase activity
- mRNA binding
- RNA binding
- RNA cap binding
- RNA helicase activity
- translation factor activity, RNA binding
- translation initiation factor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- ATP-dependent RNA helicase DEAD-box, conserved site
- Helicase, C-terminal domain-like
- DEAD/DEAH-box helicase domain
- Helicase superfamily 1/2, ATP-binding domain
- RNA helicase, DEAD-box type, Q motif
- P-loop containing nucleoside triphosphate hydrolase
- ATP-dependent RNA helicase eIF4A, DEAD-box helicase domain
- DEAD/DEAH box helicase
- Helicase conserved C-terminal domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of EIF4A1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads EIF4A1 as an antibody target. Whether an autoantibody or antibody against EIF4A1 could matter depends on whether native EIF4A1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
EIF4A1 is annotated at the cell surface, where native EIF4A1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label EIF4A1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...